Surgical Management of Gynecomastia: A Review of the Current Insurance Coverage Criteria

Yvonne M. Rasko, Carly Rosen, Ledibabari M. Ngaage, Sara AlFadil, Adekunle Elegbede, Chinezi Ihenatu, Arthur J. Nam, Sheri Slezak

Research output: Contribution to journalReview article

Abstract

BACKGROUND: Gynecomastia is a common condition that can be corrected with surgical excision of the breast tissue. Unlike the policies available for reduction mammaplasty in women, gynecomastia policies are variable and not based on strong scientific evidence. This study reviews U.S. insurance policies for coverage of gynecomastia surgery and compares these policies to the guidelines put forth by the American Society of Plastic Surgeons. METHODS: Sixty U.S. insurance companies were selected based on their market share value. Medicare was also evaluated. The policy for each company was identified using a Web-based search or by contacting the company directly. Policies were reviewed to abstract coverage criteria. All information gathered was compared to national recommendations. RESULTS: Of the 61 companies evaluated, 38% did not have a well-defined policy for gynecomastia surgery and assessed each request on a case-by-case basis with no defined criteria. The remaining 62% of providers held a defined policy. Companies often required thorough documentation of breast size, body mass index, extent and duration of symptoms, and prior treatments, but requirements varied between insurers. Many of these policies were limited in their coverage, e.g. they would cover tissue excision but not liposuction. Fourteen companies would consider of coverage for patients younger than 18 years. CONCLUSIONS: Coverage of gynecomastia surgery varies across insurers. Insurance company considerations do not often align with patient concerns and physician recommendations on gynecomastia and its treatment options. Coverage criteria should be reevaluated and universally established, to expand access to care and improve treatment efficiency.

Original languageEnglish (US)
Pages (from-to)1361-1368
Number of pages8
JournalPlastic and reconstructive surgery
Volume143
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Gynecomastia
Insurance Coverage
Insurance Carriers
Insurance
Breast
Lipectomy
Mammaplasty
Medicare
Documentation
Body Mass Index
Therapeutics
Guidelines
Physicians

ASJC Scopus subject areas

  • Surgery

Cite this

Surgical Management of Gynecomastia : A Review of the Current Insurance Coverage Criteria. / Rasko, Yvonne M.; Rosen, Carly; Ngaage, Ledibabari M.; AlFadil, Sara; Elegbede, Adekunle; Ihenatu, Chinezi; Nam, Arthur J.; Slezak, Sheri.

In: Plastic and reconstructive surgery, Vol. 143, No. 5, 01.05.2019, p. 1361-1368.

Research output: Contribution to journalReview article

Rasko, YM, Rosen, C, Ngaage, LM, AlFadil, S, Elegbede, A, Ihenatu, C, Nam, AJ & Slezak, S 2019, 'Surgical Management of Gynecomastia: A Review of the Current Insurance Coverage Criteria', Plastic and reconstructive surgery, vol. 143, no. 5, pp. 1361-1368. https://doi.org/10.1097/PRS.0000000000005526
Rasko, Yvonne M. ; Rosen, Carly ; Ngaage, Ledibabari M. ; AlFadil, Sara ; Elegbede, Adekunle ; Ihenatu, Chinezi ; Nam, Arthur J. ; Slezak, Sheri. / Surgical Management of Gynecomastia : A Review of the Current Insurance Coverage Criteria. In: Plastic and reconstructive surgery. 2019 ; Vol. 143, No. 5. pp. 1361-1368.
@article{6f57a9035cec4c43b25c7f88842df85d,
title = "Surgical Management of Gynecomastia: A Review of the Current Insurance Coverage Criteria",
abstract = "BACKGROUND: Gynecomastia is a common condition that can be corrected with surgical excision of the breast tissue. Unlike the policies available for reduction mammaplasty in women, gynecomastia policies are variable and not based on strong scientific evidence. This study reviews U.S. insurance policies for coverage of gynecomastia surgery and compares these policies to the guidelines put forth by the American Society of Plastic Surgeons. METHODS: Sixty U.S. insurance companies were selected based on their market share value. Medicare was also evaluated. The policy for each company was identified using a Web-based search or by contacting the company directly. Policies were reviewed to abstract coverage criteria. All information gathered was compared to national recommendations. RESULTS: Of the 61 companies evaluated, 38{\%} did not have a well-defined policy for gynecomastia surgery and assessed each request on a case-by-case basis with no defined criteria. The remaining 62{\%} of providers held a defined policy. Companies often required thorough documentation of breast size, body mass index, extent and duration of symptoms, and prior treatments, but requirements varied between insurers. Many of these policies were limited in their coverage, e.g. they would cover tissue excision but not liposuction. Fourteen companies would consider of coverage for patients younger than 18 years. CONCLUSIONS: Coverage of gynecomastia surgery varies across insurers. Insurance company considerations do not often align with patient concerns and physician recommendations on gynecomastia and its treatment options. Coverage criteria should be reevaluated and universally established, to expand access to care and improve treatment efficiency.",
author = "Rasko, {Yvonne M.} and Carly Rosen and Ngaage, {Ledibabari M.} and Sara AlFadil and Adekunle Elegbede and Chinezi Ihenatu and Nam, {Arthur J.} and Sheri Slezak",
year = "2019",
month = "5",
day = "1",
doi = "10.1097/PRS.0000000000005526",
language = "English (US)",
volume = "143",
pages = "1361--1368",
journal = "Plastic and Reconstructive Surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Surgical Management of Gynecomastia

T2 - A Review of the Current Insurance Coverage Criteria

AU - Rasko, Yvonne M.

AU - Rosen, Carly

AU - Ngaage, Ledibabari M.

AU - AlFadil, Sara

AU - Elegbede, Adekunle

AU - Ihenatu, Chinezi

AU - Nam, Arthur J.

AU - Slezak, Sheri

PY - 2019/5/1

Y1 - 2019/5/1

N2 - BACKGROUND: Gynecomastia is a common condition that can be corrected with surgical excision of the breast tissue. Unlike the policies available for reduction mammaplasty in women, gynecomastia policies are variable and not based on strong scientific evidence. This study reviews U.S. insurance policies for coverage of gynecomastia surgery and compares these policies to the guidelines put forth by the American Society of Plastic Surgeons. METHODS: Sixty U.S. insurance companies were selected based on their market share value. Medicare was also evaluated. The policy for each company was identified using a Web-based search or by contacting the company directly. Policies were reviewed to abstract coverage criteria. All information gathered was compared to national recommendations. RESULTS: Of the 61 companies evaluated, 38% did not have a well-defined policy for gynecomastia surgery and assessed each request on a case-by-case basis with no defined criteria. The remaining 62% of providers held a defined policy. Companies often required thorough documentation of breast size, body mass index, extent and duration of symptoms, and prior treatments, but requirements varied between insurers. Many of these policies were limited in their coverage, e.g. they would cover tissue excision but not liposuction. Fourteen companies would consider of coverage for patients younger than 18 years. CONCLUSIONS: Coverage of gynecomastia surgery varies across insurers. Insurance company considerations do not often align with patient concerns and physician recommendations on gynecomastia and its treatment options. Coverage criteria should be reevaluated and universally established, to expand access to care and improve treatment efficiency.

AB - BACKGROUND: Gynecomastia is a common condition that can be corrected with surgical excision of the breast tissue. Unlike the policies available for reduction mammaplasty in women, gynecomastia policies are variable and not based on strong scientific evidence. This study reviews U.S. insurance policies for coverage of gynecomastia surgery and compares these policies to the guidelines put forth by the American Society of Plastic Surgeons. METHODS: Sixty U.S. insurance companies were selected based on their market share value. Medicare was also evaluated. The policy for each company was identified using a Web-based search or by contacting the company directly. Policies were reviewed to abstract coverage criteria. All information gathered was compared to national recommendations. RESULTS: Of the 61 companies evaluated, 38% did not have a well-defined policy for gynecomastia surgery and assessed each request on a case-by-case basis with no defined criteria. The remaining 62% of providers held a defined policy. Companies often required thorough documentation of breast size, body mass index, extent and duration of symptoms, and prior treatments, but requirements varied between insurers. Many of these policies were limited in their coverage, e.g. they would cover tissue excision but not liposuction. Fourteen companies would consider of coverage for patients younger than 18 years. CONCLUSIONS: Coverage of gynecomastia surgery varies across insurers. Insurance company considerations do not often align with patient concerns and physician recommendations on gynecomastia and its treatment options. Coverage criteria should be reevaluated and universally established, to expand access to care and improve treatment efficiency.

UR - http://www.scopus.com/inward/record.url?scp=85065450018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065450018&partnerID=8YFLogxK

U2 - 10.1097/PRS.0000000000005526

DO - 10.1097/PRS.0000000000005526

M3 - Review article

C2 - 31033818

AN - SCOPUS:85065450018

VL - 143

SP - 1361

EP - 1368

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

SN - 0032-1052

IS - 5

ER -